Antifungal effect in selected natural compounds and probiotics and their possible use in prophylaxis of vulvovaginitis;Antifungální účinek u vybraných přírodních látek a probiotik, jejich možnosti použití v profylaxi vulvovaginitidy

Ceska Gynekologie

Volumn 70, Issue 5, 2005, Pages 395-399

  Hronek, M ^a   Vachtlova D ^a   Kudlackova Z ^a   Jilek P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antifugal effects; Natural compounds; Probiotics; Vulvovaginitis; Zinc

Indexed keywords

ALLIUM PORUM EXTRACT; ALPHA TOCOPHEROL; CLOVE OIL; ESSENTIAL OIL; GARLIC EXTRACT; NATURAL PRODUCT; PROBIOTIC AGENT; TEA TREE OIL; UNCLASSIFIED DRUG; ZINC; ANTIFUNGAL AGENT; PLANT MEDICINAL PRODUCT;

ANTIFUNGAL ACTIVITY; CANDIDA; CANDIDA ALBICANS; CANDIDA CRUSEI; CANDIDA GUILLIERMONDII; CANDIDA NORVENGENSIS; CANDIDA TROPICALIS; CLOVE; DRUG SENSITIVITY; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; LEEK; MINIMUM INHIBITORY CONCENTRATION; PEPPER; PROPHYLAXIS; REVIEW; VAGINA CANDIDIASIS; VULVOVAGINITIS; CHEMISTRY; FEMALE; PHYTOTHERAPY;

ANTIFUNGAL AGENTS; FEMALE; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; PROBIOTICS; VULVOVAGINITIS;

EID: 24044534153     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Abd, E., Hady, F. K., Hegazi, A. G. Egyptian propolis: 2 chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis. Z. Naturforsch., 2002, 57, p. 386-394.
2. Amber, W. Yoghurt: Still a favorite for vaginal candidiasis? J. National Med. Ass., 2002, 94, 4, p. 10-12.
3. Arora, D. S., Kaur, J. Antimicrobial activity of spices. Int. Antimicrob. Agents., 1999, 12, p. 257-262.
4. Bingham, J. S. What to do with patient with reccurent vulvovaginal candidiasis. Sexual. Transmitted Infect., 1999, 75, 4, p. 225-228.
5. Bonetti, A., Morelli, L., Campominosi, E., et al. Adherence of Lactobacillus plantarum P 17630 in soft-gel capsule formulation versus DA derlein's bacillus in tablet formulation to vaginal epithelial cells. Minerva Gynecol., 2003, 55, 3, p. 270-287.
6. Bruce, A. W., Reid, G. Probiotics and the urologist. Can. J. Urol., 2003, 10, 2, p. 1785-1789.
7. Canon, J. P., Lee, T. A., Bolanos, J. T., Danziger, L. H. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis., 2005, 24, 1, p. 31-40.
8. Demirezen, S. The Lactobacilli-Candida relationship in cervico vaginal smears. Cent. Eur. J. Public. Health, 2002, 10, p. 97-99.
9. Ergin, A., Arikan, S. Comparison of microdilution and disc diffusion methods in assesing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. J. Chemother., 2002, 14, 5, p. 465-472.
10. Ertekin, M. V., Uslu, H., Karslioglu, I., et al. Effect of oral zinc supplementation on agents of oropharyngeal infection in patients receiving radiotherapy for head and neck cancer. J. Int. Med. Res., 2003, 31, 4, p. 253-266.
11. Ferrer, J. Vaginal candidosis: epidemiological and etiological factors. Int. J. Gynaecol. Obstet., 2000, 1, p. 21-27.
12. Hegazi, A. G., Abd, El. Hady, F. K., Abd, Allah, F. A. Chemical composition and antimicrobial activity of European propolis. Z. Naturfrosch., 2000, 55, p. 70-75.
13. Konstantin, M. B., Sartorelli, P., Limberger, R., et al. Essential oils from Piper cernuum and Piper regnellii: antimicrobial activities and analysis by GC/MS and 13C-NMR. Planta. Med., 2001, 67, p. 771-773.
14. Kujumgiev, A., Tsvetkova, I., Serkedjieva, Y., et al. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol., 1999, 64, p. 235-240.
15. Land, M. H., Rouster-Stevens, K., Woods, C. R., Canon, M. L. Lactobacillus sepsis associated with probiotic therapy. Pediatrics., 2005, 115, 1, p. 178-182.
16. Lemar, K. M., Turner M. P., Lloyd, D. Garlic (Allium sativum) as an anti-Candida agent:a comparison of the efficacy of fresh garlic and freeze-dried extracts. J. Appl. Microbiol., 2002, 93, p. 398-405.
17. Mastromarino, P., Brigidi, P., Macchia, S., et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J. Appl. Microbiol., 2002, 93, p. 884-893.
18. Morandi, M. V., Martinez, R., Vannoucchi, H. Dietary vitamin E supplementation does not inhibit Candida albicans intestinal translocation in rats. J. Nutr. Sci. Vitaminol., 1999, 45, p. 153-161.
19. Ocana, V. S., Nader-Marcias, M. E. Vaginal lactobacilli: self- and co-aggregating ability. Br. J. Biomed. Sci., 2002, 59, p. 183-190.
20. Ota, C., Unterkircher, C., Fantinato, V., Shimizu, M. T. Antifungal activity of propolis on different species of Candida.Mycoses. Microbiological Res., 2001, 44, p. 375-378.
21. Petti, S., Tarsitani, G., D'Arca, A. S. A randomized clinical trial of the effect of yoghurt on the salivary microflora. Arch. Oral. Biol., 2001, 46, p. 705-712.
22. Reid, G., Bruce, A. W. Urogenital infections in women: can probiotics help? Postgrad. Med. J., 2003, 79, p. 428-432.
23. Reid, G., Charbonneu, D., Erb, J., et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alter vaginal flora: randomized, placebo-controlled trial in 64 healthy women. Immunol. Med. Microbiol., 2003, 35, 2, p. 131-134.
24. Renault, S., De Lucca, A. J., Boue, S., et al. CAY-1, a novel antifungal compound from cayenne proper. Med. Mycol., 2003, 41, 1, p. 75-81.
25. Sasaki, J., Kita, T., Ishita, K., Uchisawa, H., Matsue, H. Antibacterial activity of garlic powder against Escherichia coli O-157. J. Nutr. Sci. Vitaminol. (Tokyo), 1999, 45, p. 785-790.
26. Teak, S. M., Yin, M. C. In-vitro antimicrobial activity of four diallyl sulphides occuring naturally in garlic and Chinese leek oils. J. Med. Microbiol., 2001, 50, p. 646-649.
27. Vazquez, J. A., Zawawi, A. A. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin. Trials., 2002, 3, 5, p. 379-385.